A Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Cancer

NCT04854668 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

748

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Anlotinib hydrochloride capsule
DRUG: Bevacizumab
DRUG: Oxaliplatin
DRUG: Capecitabine

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.